[2024 Medical Fee Revision Implemented: Survey on Impact on Medical Corporations] – PR TIMES

This news, which surveyed the impact of the FY2024 medical fee revision on the management of medical corporations, once again highlights the importance of management strategies in the rapidly changing healthcare industry. Specifically, revision details such as stricter facility standards and adjustments to nursing staffing levels are urgent issues directly related to maintaining and improving profitability for individual medical institutions, especially small and medium-sized clinics and hospitals.

From the perspective of medical M&A and business succession, this medical fee revision should not be viewed merely as an event of cost increase or decrease, but rather positioned as a crucial trigger in formulating mid-to-long-term management strategies and, consequently, business succession strategies. Mergers and group formations pursuing economies of scale can be effective means to facilitate the maintenance of facility standards, distribute the burden of capital investment, and smoothly utilize systems such as regional medical cooperation promotion corporations. This enables enhanced adaptability to revision details that are difficult to address independently, thereby building a sustainable management foundation.

To readers facing issues with management or succession, we wish to convey the importance of closely monitoring trends in medical fee revisions and, while comparing them with their own institution's financial status, considering options for business succession or collaboration from an early stage. Strategic business succession, planned with the revision cycle in mind, can be a turning point towards new growth opportunities, rather than simply 'cessation of business'.